Euclidean Capital LLC
CIK 0001825034 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$439.8M
2026 Q2
Positions
11
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
VEU
VANGUARD INTL EQUITY INDEX F
61.8%
VTV
VANGUARD INDEX FDS
25.8%
INDA
ISHARES TR
4.2%
ORIC
ORIC PHARMACEUTICALS INC
2.4%
TMS
TEAMSHARES INC
2.1%
FHTX
FOGHORN THERAPEUTICS INC
1.7%
PMVP
PMV PHARMACEUTICALS INC
0.8%
ALEC
ALECTOR INC
0.6%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.